Streetbeat News

Price Targets

HOVR

EF Hutton has initiated coverage on New Horizon Aircraft (NASDAQ:HOVR) with a Buy rating and set a price target of $2.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:56 pm

B

DA Davidson has downgraded Barnes Group (NYSE:B) from Buy to Neutral and lowered its price target from $52 to $47.5.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:55 pm

MCK

Leerink Partners has maintained an 'Outperform' rating on McKesson but lowered the price target from $665 to $630.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:54 pm

COR

Leerink Partners has maintained an 'Outperform' rating on Cencora (NYSE:COR) but has slightly lowered the price target from $277 to $275.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:51 pm

UBER

Truist Securities has maintained its Buy rating on Uber Technologies and raised the price target from $88 to $99, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:37 pm

WBA

Truist Securities has maintained a Hold rating on Walgreens Boots Alliance (WBA) but lowered its price target from $13 to $10, indicating a cautious outlook on the stock.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:35 pm

PNTG

Truist Securities analyst David Macdonald maintains a Hold rating on Pennant Group (NASDAQ:PNTG) and raises the price target from $34 to $38.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:34 pm

PEP

PepsiCo, Inc. (NASDAQ:PEP) is set to release its Q3 earnings on Oct. 8, with expected earnings of $2.29 per share and revenue of $23.82 billion. The company offers a 3.23% annual dividend yield, translating to $1.3550 per share quarterly. Analysts have recently adjusted their price targets for PepsiCo, with RBC Capital lowering it to $176 and Barclays to $186.

Portfolio Pulse from Avi Kapoor

October 07, 2024 | 12:34 pm

MD

Truist Securities has maintained a Hold rating on Pediatrix Medical Group (NYSE:MD) while raising the price target from $10 to $13.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:33 pm

FMS

Truist Securities has maintained a Hold rating on Fresenius Medical Care (NYSE:FMS) while raising the price target from $22 to $23.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:31 pm